The impact of casirivimab-imdevimab antibody cocktail in patients amidst and post COVID 19 treatment: A retro-prospective comparative study in India

The impact of casirivimab-imdevimab antibody cocktail in patients amidst and post COVID 19 treatment: A retro-prospective comparative study in India

Background: Monoclonal antibodies have gained attention in developing countries owing to its benefits portrayed by few clinical trials. However, no studies until now have been undergone in India. Methods: A retro-prospective comparative observational study was conducted in symptomatic COVID19 patien...

Full description

Bibliographic Details
Main Authors: Aneesh Puthiyedath Joy, Anitha Theresa Augustine, Mohammed Salim Karattuthodi, Jaffer Chalil Parambil, Dilip Chandrasekher, P. Danisha, Linu Mohan Panakkal, Madhav A. Joshi, K.T. Azharul Haque, Irshad K. Mohammed Izudheen, Shadia Badaruddeen, Riya Sara John, Sarath Murali, Ardhra Rose Thomas, Fathimath Sahla, Shahir Ahmed KV. Ahmed Unni, Raseel Omar Ahmed, Shinu Cholamugath
Format: Article
Language:English
Published: Elsevier 2022-03-01
Series:Clinical Epidemiology and Global Health
Subjects:
COVID19
Casirivimab
Imdevimab
Mortality
Monoclonal antibody cocktail
Post-COVID patient Feedback
Online Access:http://www.sciencedirect.com/science/article/pii/S2213398422000070

Internet

http://www.sciencedirect.com/science/article/pii/S2213398422000070

Similar Items